Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

ORATORIO-HAND: Results of the Primary Analysis of Ocrelizumab vs Placebo in Primary Progressive Multiple Sclerosis, Including Older Patients and Those With More Advanced Disease

Author:Giovannoni, Gavin   Airas, Laura   Bove, Riley   Cutter, Gary   Hobart, Jeremy   Kuhle, Jens   Montalban, Xavier   Tur, Carmen   Wolinsky, Jerry   Schneble, Hans-Martin   Baldinotti, Anna   Bonati, Ulrike   Giacobino, Caroline   Wang, Qing   Yang, Ke   Oh, Jiwon   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Multiple Sclerosis  

Program Number:S40.001  

Author Institution:Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK and Blizard Institute, Queen Mary University, London, UK, London, United Kingdom  University of Turku, Turku, Finland, Turku, Finland  UCSF Weill Institute for Neuroscience, Department of Neurology, University of California San Francisco, San Francisco, CA, USA, CA  The University of Alabama at Birmingham, School of Public Health, Birmingham, AL, USA, Birmingham, AL  Peninsula Medical School, Plymouth University, UK, Plymouth, United Kingdom  MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland, Switzerland  Centre d'Esclerosi Múltiple de Catalunya, Vall d'Hebron University Hospital, Barcelona, Spain, Barcelona, Spain  Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), London, UK/Neurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia (CEMCAT), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain, Un  Department of Neurology, University of Texas Health Science Center, Houston, TX, USA, TX  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Switzerland  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada, ON, Canada  

Efficacy and Safety of Fenebrutinib vs Ocrelizumab in Primary Progressive Multiple Sclerosis: Primary Results of the Phase III FENtrepid Study

Author:Bar-Or, Amit   Oh, Jiwon   Giovannoni, Gavin   Sormani, Maria Pia   Weber, Martin S.   Stoll, Sharon   Nicholas, Jacqueline A.   Büdingen, H.-Christian von   Lopez, Jon   Roberts, Louise   Triyatni, Miriam   Qi, Qi   Ratchford, John N.   Napieralski, Julie   Goodyear, Alexandra   Hauser, Stephen L.   Kappos, Ludwig   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Multiple Sclerosis  

Program Number:S40.004  

Author Institution:Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA  St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada, Toronto, ON, Canada  Queen Mary University of London, London, UK, London, United Kingdom  University of Genoa, Genoa, Italy, Genoa, Italy  Institute of Neuropathology and Department of Neurology, University Medical Center and Fraunhofer Institute for Translational Medicine and Pharmacology, Göttingen, Germany, Göttingen, Germany  Advocare Stoll Medical Group, Philadelphia, PA, USA, Philadelphia, PA  OhioHealth Multiple Sclerosis Centre, Riverside Methodist Hospital, Columbus, OH, USA, Columbus, OH  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Genentech, Inc., South San Francisco, CA, USA, South San Francisco, CA  University of California San Francisco, San Francisco, CA, USA, San Francisco, CA  University Hospital and University Basel, Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Basel, Switzerland, Basel, Switzerland  

Real-world Digital Biomarkers Associated With Their Clinical Counterparts in the MS-DETECT Study

Author:Vermersch, Patrick   Filippi, Massimo   Oreja-Guevara, Celia   Oh, Jiwon   Sejbæk, Tobias   Graves, Jennifer   Klaeylé, Lissandra   Bieuvelet, Séverine   Carment, Loïc   DROUIN, Pierre   Zinaï, Saad   Rufi, Pascal   Padrazzi, Bruno   Ziemssen, Tjalf   

Session Name:P4: Multiple Sclerosis: Digital Health, Biomarkers, and Artificial Intelligence 1  

Topic:Multiple Sclerosis  

Program Number:P4.004  

Author Institution:Univ. Lille, UMR Inserm U1172, CHU Lille, Lille, France, Lille, France  Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy, Milan, Italy  Hospital Clinico San Carlos, IdISSC, Madrid, Spain, Madrid, Spain  Division of Neurology, St. Michael’s Hospital, University of Toronto, Toronto, Canada, Toronto, ON, Canada  Department of Neurology, Esbjerg Hospital, University Hospital of Southern Denmark, Esbjerg, Denmark, Esbjerg, Denmark  Department of Neurosciences, University of California San Diego, San Diego, CA, USA, San Diego, CA  Ad Scientiam, Paris, France, Paris, France  Sanofi, Paris, France, Chilly-Mazerins, France  MS Center, Center of Clinical Neuroscience, Neurological Clinic, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany, Dresden, Germany  

Outsmarting Therapeutic Inertia: Can ChatGPT-4o Beat Neurologists in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Care?

Author:Gómez, Rocío   Solanes, Aleix   Monreal Laguillo, Enric   Sepúlveda, Maria   Pérez Sempere, Ángel   Hernandez Perez, Miguel Angel   Cuello, Juan Pablo   Álvarez-Bravo, Gary   Aguera Morales, Eduardo   Riancho, Javier   García-Arcelay, Elena   Maurino, Jorge   Saposnik, Gustavo   

Session Name:P6: Multiple Sclerosis: Digital Health, Biomarkers, and Artificial Intelligence 3  

Topic:Multiple Sclerosis  

Program Number:P6.001  

Author Institution:Roche Farma S.A., Madrid, Spain  Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain, Spain  Hospital Universitario Ramón y Cajal, Madrid, Spain, Spain  Hospital Clínic de Barcelona, Barcelona, Spain, Barceolona, Spain  Hospital General Universitario de Alicante, Alicante, Spain, Spain  Hospital Nuestra Senora de Candelaria, Tenerife, Spain, Tenerife, Spain  Hospital Universitario Gregorio Marañón, Madrid, Spain, Madrid, Spain  Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain, Spain  Hospital Universitario Reina Sofía, Córdoba, Spain, Cordoba, Spain  Hospital Sierrallana-Institute of Research Valdecilla (IDIVAL), Torrelavega, Spain, Spain  Roche Farma S.A., Spain  St. Michael´s Hospital, University of Toronto, Toronto, Canada, Toronto, ON, Canada  

Creation of Patient-centered Educational Videos for Glucocorticoid Treatment Counselling

Author:Zhu, Annie   Kassardjian, Charles   

Session Name:P6: Neuromuscular and Clinical Neurophysiology (EMG): Peripheral Nerve and Other Neuromuscular Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P6.016  

Author Institution:University of Toronto, Toronto, ON, Canada  St. Michael's Hospital, Toronto, ON, Canada